Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement - Woo, P; Wilkinson, N; Prieur, AM (Arthritis Res Ther, 2005)
et al.